Latham & Watkins represented Trinity Capital in the transaction. Openly Holdings Corp. a premium homeowners insurance company, has secured financing of up to US$40 million from...
Openly’s $40 Million Growth Investment
Bending Spoons’ Acquisition of Evernote
Latham & Watkins represented Evernote in the transaction. Willkie advised Bending Spoons. Bending Spoons, a leading European technology company, has announced an agreement to acquire Evernote,...
Outset Medical’s $300 Million Debt Facilities
Cooley LLP advised Outset, while Latham & Watkins LLP represented SLR Capital Partners in the transaction. Outset Medical, Inc. (Nasdaq: OM), a medical technology company pioneering...
Kura Oncology’s $125 Million Financing Agreement
Latham & Watkins LLP represented Hercules Capital, Inc. in the transaction. Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision...
Tricida’s $125 Million Debt Facility
Latham & Watkins LLP represented Hercules in the transaction. Tricida, Inc. (Nasdaq: TCDA) has entered into a debt facility with Hercules Capital, Inc. (NYSE: HTGC), a...
Bottomline Technologies’ Acquisition of Nexus Systems
Latham & Watkins represented Nexus Systems in the transaction. Bottomline Technologies executed the acquisition of Nexus Systems. Terms were not disclosed. Nexus Systems, a leading provider of accounts...
Alignment Healthcare’ $250 Million Debt Financing
Latham & Watkins represented Alignment Healthcare in the transaction. Alignment Healthcare, Inc.(Alignment Healthcare) (NASDAQ: ALHC), a leading tech-enabled MedicareAdvantage company, has announced the close of an...
Atai Life Sciences’ $175 Million Venture Debt Financing
Latham & Watkins and Dentons represented atai in the transaction. atai Life Sciences (“atai”) announced the closing of a venture debt loan facility of up to...
Rhythm Pharmaceuticals’ $100 Million Revenue Interest Financing Agreement With HealthCare Royalty Partners
Latham & Watkins represented Rhythm Pharmaceuticals, Inc. in the transaction, while Morgan, Lewis & Bockius acted as legal advisor to HealthCare Royalty. Rhythm Pharmaceuticals, Inc. (Nasdaq:...
FirstClose’s $35 Million Funding Round
Latham & Watkins represented Lateral Investment Management on the transaction. FirstClose, a leading property and borrower data intelligence provider, has closed a US$35 million funding round...
BridgeBio Pharma’s Credit Facility Amendment
Latham & Watkins advised BridgeBio on the deal. BridgeBio Pharma, Inc. (Nasdaq: BBIO) (BridgeBio), a commercial-stage biopharmaceutical company focused on genetic diseases and cancers, has entered into...
Impulse Dynamics’ $101 Million Financing Round
Latham & Watkins represented Kennedy Lewis Investment Management LLC in the transaction. Impulse Dynamics, a global medical device company a medical device company organized in Curacao...